miRNA-34c suppresses osteosarcoma progression in vivo by targeting Notch and E2F
Y. Bae, H.-C. Zeng, Y.-T. Chen, S. Ketkar, E. Munivez, Z. Yu, F. H. Gannon, B. H. Lee
This study shows miR-34c suppresses osteosarcoma progression by targeting Notch and E2F pathways, improving survival in mouse models and correlating with better patient outcomes.
bioRxiv · May 24, 2021Cancer Biology